Abstract:Highlights • Synthetic lethality offers a promising means for expanding drug target space for cancer treatment. • We developed a knowledge and data dual-driven AI framework for synthetic lethality prediction (KDDSL). • KDDSL is a "visible" AI framework that integrates domain knowledge to explore synthetic lethality and its implications in cancer treatment. This "visible" framework enhances the trust between biologists and AI. • KDDSL can help in identifying SL interactions and guiding the design of synergistic anti-cancer combination therapies. • By applying KDDSL, we identified the combination of MDM2 and CDK9 inhibitors, which demonstrated significant anticancer effects in vitro and in vivo. Introduction Synthetic lethality (SL) provides an opportunity to leverage different genetic interactions when designing synergistic combination therapies. To further explore SL-based combination therapies for cancer treatment, it is important to identify and mechanistically characterize more SL interactions. Artificial intelligence (AI) methods have recently been proposed for SL prediction, but the results of these models are often not interpretable such that deriving the underlying mechanism can be challenging. Objectives This study aims to develop an interpretable AI framework for SL prediction and subsequently utilize it to design SL-based synergistic combination therapies. Methods We propose a knowledge and data dual-driven AI framework for SL prediction (KDDSL). Specifically, we use gene knowledge related to the SL mechanism to guide the construction of the model and develop a method to identify the most relevant gene knowledge for the predicted results. Results Experimental and literature-based validation confirmed a good balance between predictive and interpretable ability when using KDDSL. Moreover, we demonstrated that KDDSL could help to discover promising drug combinations and clarify associated biological processes, such as the combination of MDM2 and CDK9 inhibitors, which exhibited significant anti-cancer effects in vitro and in vivo . Conclusion These data underscore the potential of KDDSL to guide SL-based combination therapy design. There is a need for biomedicine-focused AI strategies to combine rational biological knowledge with developed models. Graphical abstract KDDSL open the black box of neural network to achieve interpretable prediction of SL (The two shields represent two SL genes). This can help us utilize SL to kill cancer cell. Download : Download high-res image (92KB) Download : Download full-size image

Harnessing synthetic lethality to predict the response to cancer treatment

Synthetic Lethality: a Promising Therapeutic Strategy for Hepatocellular Carcinoma.

SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment

ELISL: early-late integrated synthetic lethality prediction in cancer

The tumor therapy landscape of synthetic lethality

Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens

Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer

CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference

Computational methods, databases and tools for synthetic lethality prediction

Abstract 5813: AI-driven identification and validation of novel synthetic lethal gene pairs through deep mining of cancer dependency data

An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies

Benchmarking machine learning methods for synthetic lethality prediction in cancer

Potential promising of synthetic lethality in cancer research and treatment

A multilineage screen identifies actionable synthetic lethal interactions in human cancers

Synthetic lethality-mediated precision oncology via the tumor transcriptome

ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic Interactions

Synthetic lethality as an engine for cancer drug target discovery

SL$^2$MF: Predicting Synthetic Lethality in Human Cancers via Logistic Matrix Factorization

Mapping the landscape of synthetic lethal interactions in liver cancer

EXP2SL: A Machine Learning Framework for Cell-Line-Specific Synthetic Lethality Prediction.

Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population